EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Plasma Protein Biomarkers and Long‐Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart Disease

Ralph A H Stewart iD, Kristy P Robledo iD, Andrew M Tonkin iD, Anthony Keech iD, Leonard Kritharides iD, Ian Marschner iD, Edward Janus iD, Peter L Thompson, Gerald F Watts iD, Tanja Zeller, Harvey D White iD, John Simes iD

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.123.034367 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Ralph A H Stewart und 11 weiteren Autor:innen. Beteiligte Einrichtung: Green Lane Cardiovascular Service, Auckland City Hospital, Te Toka Tumai, Te Whatu Ora-Health New Zealand Auckland New Zealand. Hauptthemen laut MEDLINE: Biomarkers, Coronary Disease, Cystatin C, Natriuretic Peptide, Brain. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Protein biomarkers that reflect different pathophysiological pathways have been associated with the risk of adverse cardiovascular events. However, it is uncertain whether these associations are sustained with increasing years after the biomarkers are measured. Methods and Results In this cohort study, 7745 patients with coronary heart disease who participated in the LIPID (Long‐Term Intervention With Pravastatin in Ischemic Disease) trial, BNP (B‐type natriuretic peptide), troponin I, cystatin‐C, C‐reactive protein, d ‐dimer and midregional proadrenomedullin were measured at baseline and after 1 year. Discrimination of plasma biomarker concentrations for cardiovascular death were evaluated in landmark analyses from 1 year for the next 5 years of the randomized trial, and for 10 additional years after trial completion. All 6 biomarkers were associated with risk of cardiovascular death (n=1903) both during and after the clinical trial (each P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersCoronary DiseaseCystatin CNatriuretic Peptide, BrainAdrenomedullinC-Reactive ProteinTroponin IFibrin Fibrinogen Degradation ProductsHumansMaleFemaleAgedMiddle AgedChronic DiseaseRisk AssessmentTime FactorsPravastatinRisk FactorsHydroxymethylglutaryl-CoA Reductase InhibitorsBlood ProteinsProtein Precursors

Stichwörter der Autor:innen

biomarkerscardiovascular riskcoronary heart diseasedeathlong‐term survival

Substanzen

BiomarkersCystatin CNatriuretic Peptide, BrainAdrenomedullinC-Reactive ProteinTroponin IFibrin Fibrinogen Degradation Productsfibrin fragment DPravastatinCST3 protein, human

Autor:innen und Institutionen

  • Green Lane Cardiovascular Service, Auckland City Hospital, Te Toka Tumai, Te Whatu Ora-Health New Zealand Auckland New Zealand.
  • Faculty Medicine and Health, NHMRC Clinical Trials Centre University of Syndey and The Royal Prince Alfred Hospital Camperdown NSW Australia.
  • School of Public Health and Preventive Medicine Monash University Melbourne VIC Australia.
  • Department of Cardiology, Concord Hospital The University of Sydney Concord NSW Australia.
  • ANZAC Medical Research Institute, Faculty of Medicine, University of Sydney Concord NSW Australia.
  • Western Health Chronic Disease Alliance and Department of Medicine, Western Health-Melbourne Medical School University of Melbourne Parkville Vic 3010 Australia.

ORCID-Profile: Ralph A H Stewart, Kristy P Robledo, Andrew M Tonkin, Anthony Keech, Leonard Kritharides, Ian Marschner, Edward Janus, Gerald F Watts, Harvey D White, John Simes

Zitieren

APA

Stewart, R. A. H., Robledo, K. P., Tonkin, A. M., Keech, A., Kritharides, L., Marschner, I., Janus, E., Thompson, P. L., Watts, G. F., Zeller, T., White, H. D., & Simes, J. (2024). Plasma Protein Biomarkers and Long‐Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart Disease. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.034367

Vancouver

Stewart RAH, Robledo KP, Tonkin AM, Keech A, Kritharides L, Marschner I, et al. Plasma Protein Biomarkers and Long‐Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart Disease. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.034367

BibTeX
@article{Stewart2024,
  author = {Stewart, Ralph A H and Robledo, Kristy P and Tonkin, Andrew M and Keech, Anthony and Kritharides, Leonard and Marschner, Ian and Janus, Edward and Thompson, Peter L and Watts, Gerald F and Zeller, Tanja and White, Harvey D and Simes, John},
  title = {Plasma Protein Biomarkers and Long‐Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart Disease},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.123.034367}
}
Kostenlos starten →